Detection and clinical studies of HER-2 in gastric cancer / 国际外科学杂志
International Journal of Surgery
;
(12): 487-491, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-417104
ABSTRACT
Trastuzumab is a monoclonal antibody directed against the human epidermal growth factor receptor-2( HER-2). Recent studies found that Trastuzumab in combination with chemotherapy could improve the survival of patients with HER-2 positive advanced gastric. However, the use of techniques like immunohistochemistry, fluorescence in situ hybridization (FISH) in assessing HER-2 status of gastric cancer has many disadvantages, a new technique silver-enhanced in situ hybridization (SISH) is likely to be the reference standard for assessing HER-2 status of gastric cancer. This paper reviews the advance of the detection and clinical studies of HER-2 in gastric cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
Chinese
Journal:
International Journal of Surgery
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS